Publicacións en colaboración con investigadores/as de Universidad de Salamanca (10)

2024

  1. p63 controls metabolic activation of hepatic stellate cells and fibrosis via an HER2-ACC1 pathway

    Cell Reports Medicine, Vol. 5, Núm. 2

2023

  1. Myeloid p38 activation maintains macrophage-liver crosstalk and BAT thermogenesis through IL-12-FGF21 axis

    Hepatology, Vol. 77, Núm. 3, pp. 874-887

  2. The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent

    Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 878-895

2022

  1. Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 9, pp. 724-734

2021

  1. Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis

    Molecular Metabolism, Vol. 53

2020

  1. Vav2 catalysis-dependent pathways contribute to skeletal muscle growth and metabolic homeostasis

    Nature Communications, Vol. 11, Núm. 1

2019

  1. Vagal afferents contribute to sympathoexcitation-driven metabolic dysfunctions

    Journal of Endocrinology, Vol. 240, Núm. 3, pp. 483-496

2017

  1. MKK6 controls T3-mediated browning of white adipose tissue

    Nature Communications, Vol. 8, Núm. 1

2016

  1. P38γ and p38δ reprogram liver metabolism by modulating neutrophil infiltration

    EMBO Journal, Vol. 35, Núm. 5, pp. 536-552

2013

  1. Chronic sympathoexcitation through loss of vav3, a rac1 activator, results in divergent effects on metabolic syndrome and obesity depending on diet

    Cell Metabolism, Vol. 18, Núm. 2, pp. 199-211